Evidence map›Paper›PMID 31227227›Full record

ReviewAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2019

Ethical Issues in Pragmatic Cluster-Randomized Trials in Dialysis Facilities.

Cory E Goldstein, Charles Weijer, Monica Taljaard, Ahmed A Al-Jaishi, Erika Basile, Jamie Brehaut, Charles L Cook, Jeremy M Grimshaw, Eduardo Lacson, Craig Lindsay and 3 more

Abstract readReview
In one paragraph

Review in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Reducing Bias in Cluster Randomized Trials in Nephrology.Journal of the American Society of Nephrology : JASN · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Randomized Trials Using Provincial Health Numbers for Group Assignment.Canadian journal of kidney health and disease · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Cory E GoldsteinRotman Institute of Philosophy, Western University, London. Electronic address: cgoldst2@uwo.ca.
Charles WeijerRotman Institute of Philosophy, Western University, London.
Monica TaljaardClinical Epidemiology Program, Ottawa Hospital Research Institute; School of Epidemiology and Public Health, University of Ottawa, Ottawa.
Ahmed A Al-JaishiInstitute for Clinical Evaluative Sciences, Toronto; Department of Health and Research Methods, Evidence, and Impact, McMaster University, Hamilton.
Erika BasileOffice of Research Ethics, Western University.
Jamie BrehautClinical Epidemiology Program, Ottawa Hospital Research Institute; School of Epidemiology and Public Health, University of Ottawa, Ottawa.
Charles L CookPatient partner with the SPOR Innovative Clinical Trials Initiative, London.
Jeremy M GrimshawClinical Epidemiology Program, Ottawa Hospital Research Institute; Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
Eduardo LacsonDialysis Clinic, Inc, Nashville, TN; Tufts University School of Medicine, Boston, MA.
Craig LindsayPatient partner with the SPOR Innovative Clinical Trials Initiative, London.
Meg JardineThe George Institute for Global Health, University of New South Wales; Department of Renal Medicine, Concord Repatriation General Hospital and University of Sydney, Sydney, NSW, Australia.
Laura M DemberRenal, Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Amit X GargInstitute for Clinical Evaluative Sciences, Toronto; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton; Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

Funding

Continuation of the Coordinating Center for the Chronic Renal Insufficiency Cohort (CRIC) StudyU24DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Amanda Hyre Anderson, Laura M Dember · 2018 to 2026
$21.5M
Health Care Systems Research Collaboratory SupplementU54AT007748 · NCCIH · DUKE UNIVERSITY · PI CURTIS, LESLEY H, HERNANDEZ, ADRIAN · 2012 to 2017
$15.1M
Pragmatic Trials in Maintenance HemodialysisUH3DK102384 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI DEMBER, LAURA M · 2013 to 2016
$5.8M
Data Coordinating Center for Hemodialysis Pilot Studies ConsortiumU01DK099919 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI DEMBER, LAURA M, LANDIS, J RICHARD · 2013 to 2018
$5.2M
HiLoUG3DK118748 · NIDDK · DUKE UNIVERSITY · PI WOLF, MYLES S · 2018 to 2018
$842k
CIHRNCCIH NIH HHS U54 AT007748NIDDK NIH HHS U01 DK099919NIDDK NIH HHS U24 DK060990NIDDK NIH HHS UG3 DK118748NIDDK NIH HHS UH3 DK102384
6 · The paper itself

Abstract

A pragmatic cluster-randomized trial (CRT) is a research design that may be used to efficiently test promising interventions that directly inform dialysis care. While the Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials provides general ethical guidance for CRTs, the dialysis setting raises additional considerations. In this article, we outline ethical issues raised by pragmatic CRTs in dialysis facilities. These issues may be divided into 7 key domains: justifying the use of cluster randomization, adopting randomly allocated individual-level interventions as a facility standard of care, conducting benefit-harm analyses, gatekeepers and their responsibilities, obtaining informed consent from research participants, patient notification, and including vulnerable participants. We describe existing guidelines relevant to each domain, illustrate how they were considered in the Time to Reduce Mortality in End-Stage Renal Disease (TiME) trial (a prototypical pragmatic hemodialysis CRT), and highlight remaining areas of uncertainty. The following is the first step in an interdisciplinary mixed-methods research project to guide the design and conduct of pragmatic CRTs in dialysis facilities. Subsequent work will expand on these concepts and when possible, argue for a preferred solution.

Indexed as

Ethics, MedicalPersonal AutonomyHumansKidney Failure, ChronicPragmatic Clinical Trials as TopicRandomized Controlled Trials as TopicRenal Dialysisbiascluster-randomized trialsdialysis caredialysis facilitiesend-stage renal disease (ESRD)ethical issuesgatekeeperinformed consentintergroup contaminationIRBnephrology researchpatient adherencepatient autonomypatient protectionsPragmatic trialsrandomization typeresearch ethicsreviewstudy designwaiver

Identifiers

PMID31227227
PMCPMC6815240

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.